http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110693876-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-00 |
| filingDate | 2019-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-110693876-B |
| titleOfInvention | Application of andrographolide in the preparation of drugs for preventing or/and treating muscle damage |
| abstract | The invention discloses the application of andrographolide in the preparation of medicines or health care products for preventing or/and treating muscle damage. Tests have proved that andrographolide has the effect of overcoming muscle damage caused by hyperlipidemia, such as muscle endurance and decreased muscle strength. , to avoid muscle damage caused by statin therapy during the treatment of hyperlipidemia, especially the role of muscle sequence caused by adverse reactions such as rhabdomyolysis, so as to enhance muscle endurance and instant grip, and protect muscles; and Andrographolide also has the function of regulating blood lipids, reducing serum cholesterol, triglyceride and low-density lipoprotein cholesterol, increasing high-density lipoprotein cholesterol, reducing intracellular cholesterol content, and inhibiting the accumulation of cholesterol between smooth muscle cell collagen and elastic fibers. Avoid smooth muscle cell proliferation, anti-atherosclerosis. |
| priorityDate | 2019-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 180.